A bullpen full of quality relievers is critical at a certain point in a ballgame.  That is how I think of my watch list, which includes items I’ve already sold.  Take Amgen for instance; I told myself “don’t be greedy” and sold it at around 172, several weeks ago about 10 bucks above my original target.  I said ‘thank you fine company’ and moved on.  … Continue reading The Value of Keeping a Well Stocked Bullpen; Amgen You’re In

“Don’t be greedy” they teach us in Market Trading 101.  So, more than 10 bucks above the original target I decide to let Amgen go.  Thank you, sir. Subscribe to NFTRH Premium for your 30-45 page weekly report, interim updates and NFTRH+ chart and trade ideas or the free eLetter for an introduction to our work. Or simply keep up to date with plenty of … Continue reading Slow, Steady Profit-Taking Continues (AMGN Edition)

Amgen was highlighted in NFTRH and has been updated weekly as part of the NFTRH+, Trading Notes segment.  It seemed like the best of a difficult bunch, where Biotech was concerned and is part of a diversified portfolio of supposed Trump and anti-Trump items (AMGN theoretically being ‘anti’).  I had small losses a couple different times trying to do GILD, which has some issues with … Continue reading Amgen Trade (Investment?) Working Out Well So Far